Concomitant chemo-radiotherapy for unresectable oesophageal cancer: A mono-institutional study on 40 patients

Reports of Practical Oncology and Radiotherapy

Volumn 17, Issue 4, 2012, Pages 226-232

  Torrente, Sara ^a   Turri, Lucia ^a   Deantonio, Letizia ^a   Cena, Tiziana ^b   Gambaro, Giuseppina ^a   Magnani, Corrado ^b   Krengli, Marco ^a,b  

^a University Hospital Maggiore della Carita   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Chemotherapy; Oesophageal cancer; Radiotherapy

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CACHEXIA; CANCER CONTROL; CHEMORADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; DISEASE FREE SURVIVAL; ENDOSCOPY; ESOPHAGUS CANCER; FEMALE; GASTROINTESTINAL DISEASE; HEMATOLOGIC DISEASE; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; MALE; OVERALL SURVIVAL; RADIATION DOSE; RADIATION PNEUMONIA; RECURRENT DISEASE; TREATMENT OUTCOME;

EID: 84864082088     PISSN: 15071367     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rpor.2012.03.013     Document Type: Article

References (26)

1. Willett C.G., Czito B.G. Chemoradiotherapy in gastrointestinal malignancies. Clin Oncol 2009, 21:543-556.
2. Vizcaino A.P., Moreno V., Lambert R., et al. Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995. Int J Cancer 2002, 99:860-868.
3. Ajani J.A. In the ring with a raging bull: unresectable localized esophageal carcinoma. Onkologie 2010, 33:220-221.
4. Shitara K., Muro K. Chemoradiotherapy for treatment of esophageal cancer in Japan: current status and perspectives. Gastrointest Cancer Res 2009, 3:66-72.
5. National Comprehensive Cancer Network. Esophageal Cancer Clinical Practice Guidelines in Oncology 2010, Version 2.2010. Available from: [accessed January 2011]. http://www.nccn.org/professional/physician_gls/pdf/esophageal.pdf.
6. Oken M.M., Creech R.H., Tormey D.C., et al. Toxicity and response criteria of the eastern cooperative oncology group. Am J Clin Oncol 1982, 5:649-655.
7. Cox J.D., Stetz J., Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995, 31:1341-1346.
8. Cancer Therapy Evaluation Program Common Terminology Criteria for Adverse Events, Version 4.0 2009, DCTD, NCI, DHHS.
9. Cooper J.S., Guo M.D., Herskovic A., et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 1999, 281:1623-1627.
10. Geh J.I., Bond S.J., Bentzen S.M., et al. Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: evidence of a radiation and chemotherapy dose response. Radiother Oncol 2006, 78:236-244.
11. Chiu P.W., Chan A.C., Leung S.F., et al. Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: early results from the Chinese University Research Group for Esophageal Cancer (CURE). J Gastrointest Surg 2005, 9:794-802.
12. Herskovic A., Martz K., al-Sarraf M., et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992, 326:1593-1598.
13. Morita M., Oyama T., Nakata S., et al. Expression of FHIT in esophageal epithelium and carcinoma: reference to drinking, smoking and multicentric carcinogenesis. Anticancer Res 2006, 26:2243-2248.
14. Hurmuzlu M., Monge O.R., Smaaland R., et al. High-dose definitive concomitant chemoradiotherapy in non-metatstatic locally advanced esophageal cancer: toxicity and outcome. Dis Esophagus 2010, 23:244-252.
15. Di Fiore F., Lecleire S., Galais M.P. Impact of radiation schedule and chemotherapy duration in definitive chemoradiotherapy regimen for esophageal cancer. Gastroenterol Clin Biol 2006, 30:845-851.
16. Lordick F., Ott K., Krause B.J., et al. PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. Lancet Oncol 2007, 8:797-805.
17. Murthy S.B., Patnana S.V., Xiao L., et al. The standardized uptake value of 18-fluoro-deoxy glucose positron emission tomography after chemoradiation and clinical outcome in patients with localized gastroesophageal carcinoma. Oncology 2010, 78:316-322.
18. Ruhstaller T., Pless M., Dietrich D., et al. Cetuximab in combination with chemoradiotherapy before surgery in patients with resectable, locally advanced esophageal carcinoma: a prospective, multicenter phase IB/II trial (SAKK 75/06). J Clin Oncol 2011, 29:626-631.
19. Fabrini M.G., Perrone F., De Liguoro M., et al. A single-institutional brachytherapy experience in the management of esophageal cancer. Brachytherapy 2010, 9:185-191.
20. Skowronek J., Adamska K., Suwalska M., et al. Palliative HDR brachytherapy in treatment of advanced esophageal cancer. Rep Pract Oncol Radiother 2000, 5(4):111-119.
21. Choong N.W., Mauer A.M., Haraf D.C., et al. Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction. Med Oncol 2010, August 21 [Epub ahead of print].
22. Higuchi K., Koizumi W., Tanabe S., et al. Current management of esophageal squamous-cell carcinoma in Japan and other countries. Gastrointest Cancer Res 2009, 3:153-161.
23. Ishihara R., Yamamoto S., Iishi H., et al. Factors predictive of tumor recurrence and serviva after initial complete response of esophageal squamous cell carcinoma to definitive chemoradiotherapy. Int J Radiat Oncol Biol Phys 2010, 76:123-129.
24. Tougeron D., Di Fiore F., Thureau S., et al. Safety and outcome of definitive chemoradiotherapy in elderly patients with esophageal cancer. Br J Cancer 2008, 99:1586-1592.
25. Wolf M., Zehentmayr F., Niyazi M., et al. Long-term outcome of mitomycin C- and 5-FU-based primary radiochemotherapy for esophageal cancer. Strahlenter Onkol 2010, 86:374-381.
26. Adams R., Morgan M., Mukherjee S., et al. A prospective comparison of multidisciplinary treatment of esophageal cancer with curative intent in a UK cancer network. Eur J Surg Oncol 2007, 33:307-313.